Quantinno Capital Management LP Has $2.13 Million Stock Position in Encompass Health Co. (NYSE:EHC)

Quantinno Capital Management LP increased its position in Encompass Health Co. (NYSE:EHC - Free Report) by 48.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 23,019 shares of the company's stock after acquiring an additional 7,497 shares during the period. Quantinno Capital Management LP's holdings in Encompass Health were worth $2,126,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after buying an additional 137 shares during the last quarter. Colonial Trust Co SC bought a new stake in Encompass Health during the 4th quarter valued at $29,000. Transce3nd LLC acquired a new position in Encompass Health during the 4th quarter worth $40,000. CBIZ Investment Advisory Services LLC grew its stake in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after purchasing an additional 127 shares in the last quarter. Finally, V Square Quantitative Management LLC increased its holdings in shares of Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after purchasing an additional 177 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have commented on EHC shares. Royal Bank of Canada boosted their price target on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th. Barclays increased their price target on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. Wall Street Zen raised Encompass Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Finally, Truist Financial reiterated a "buy" rating and issued a $135.00 price target (up from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Eight research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Encompass Health currently has a consensus rating of "Buy" and a consensus price target of $120.86.

Insiders Place Their Bets

In related news, insider Elissa Joy Charbonneau sold 4,279 shares of the stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the transaction, the insider now owns 11,958 shares in the company, valued at approximately $1,394,422.38. This represents a 26.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Mark J. Tarr sold 118,384 shares of Encompass Health stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the completion of the sale, the chief executive officer now owns 527,070 shares of the company's stock, valued at $64,054,817.10. This trade represents a 18.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 132,663 shares of company stock worth $16,034,082 in the last quarter. 2.00% of the stock is currently owned by corporate insiders.

Encompass Health Trading Up 0.1%

Shares of EHC traded up $0.13 during midday trading on Monday, hitting $118.74. The stock had a trading volume of 388,011 shares, compared to its average volume of 699,207. Encompass Health Co. has a fifty-two week low of $82.74 and a fifty-two week high of $121.96. The business has a 50-day simple moving average of $107.85 and a two-hundred day simple moving average of $101.40. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. The firm has a market cap of $11.97 billion, a P/E ratio of 26.62, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The company had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the prior year, the company earned $1.12 earnings per share. The company's revenue for the quarter was up 10.6% on a year-over-year basis. As a group, equities analysts forecast that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be paid a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.68 annualized dividend and a yield of 0.57%. Encompass Health's dividend payout ratio is presently 14.05%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.